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Mesenchymal stem cells (MSCs), and within them adipose tissue derived stem cells (ASCs), have been
shown to have therapeutic effects on central nervous system (CNS) cell populations. Such effects have
been mostly attributed to soluble factors, as well as vesicles, present in their secretome. Yet, little is
known about the impact that MSC passaging might have in the secretion therapeutic proﬁle. Our aimwas
to show how human ASCs (hASCs) passage number inﬂuences the effect of their secretome in neuronal
survival, differentiation and axonal growth. For this purpose, post-natal rat hippocampal primary cul-
tures, human neural progenitor cell (hNPCs) cultures and dorsal root ganglia (DRGs) explants were
incubated with secretome, collected as conditioned media (CM), obtained from hASCs in P3, P6, P9 and
P12. Results showed no differences when comparing percentages of MAP-2 positive cells (a mature
neuronal marker) in neuronal cultures or hNPCs, after incubation with hASCs secretome from different
passages. The same was observed regarding DRG neurite outgrowth. In order to characterize the
secretomes obtained from different passages, a proteomic analysis was performed, revealing that its
composition did not vary signiﬁcantly with passage number P3 to P12. Results allowed us to identify
several key proteins, such as pigment epithelium derived factor (PEDF), DJ-1, interleucin-6 (IL-6) and
galectin, all of which have already proven to play neuroprotective and neurodifferentiating roles. Proteins
that promote neurite outgrowth were also found present, such as semaphorin 7A and glypican-1. We
conclude that cellular passaging does not inﬂuence signiﬁcantly hASCs's secretome properties especially
their ability to support post-natal neuronal survival, induce neurodifferentiation and promote axonal
growth.
© 2018 Published by Elsevier B.V.1. Introduction
Mesenchymal stem cells (MSCs) were isolated for the ﬁrst time
by Friedenstein and colleagues in 1974 [1]. Classiﬁed as a subgroup, University of Minho, 4710-
gado).
ﬂuence of passage number o
owth, Biochimie, https://doi.oof non-hematopoietic multipotent adult stem cells, they have the
ability for self-renewal and differentiation in multiple cell lines
[2,3]. It is possible to isolate them from almost all tissues, but the
most common sources for MSCs are bone marrow (BM-MSCs),
adipose tissue (ASCs) and the Wharton jelly of the umbilical cord
(WJSCs and HUCPVCs) [1,4e7].
In the scope of regenerative medicine, and specially of cell-
based therapies, the growing interest for potential applications of
MSCs is due to their broad distribution and easy access, hugen the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
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Several studies have emerged where application of MSCs is used
in Central Nervous System (CNS) repair models. Indeed, the
transplantation of MSCs has already proven to possess therapeutic
effects in animal models of Parkinson's Disease [9,10] and spinal
cord injury [11,12]. Nowadays it is well established that it is the
secretome of these cells - described as all the soluble factors and
vesicles secreted to the extracellular milieu - that acts as the main
mediator within CNS and other tissues related therapies [13e16].
Indeed, MSCs ability to promote neuronal survival and neuro-
genesis has been proven in vitro and attributed to their capability to
secrete neurotrophic factors such as BDNF and b-NGF [17]. Char-
acterization of BM-MSCs secretome, obtained as conditioned me-
dium (CM), demonstrated that theywere capable of secreting IGF-1,
HGF, VEGF and TGF-b, molecules responsible for in vitro neuronal
survival and neurogenesis [17,18]. Some growth factors were also
identiﬁed in the secretome of ASCs, such as bFGF, NGF and SCF,
along with IGF-1, HGF, VEGF and TGF-b1, capable of promoting
proliferation of neuronal and glial cells populations [13,14,19].
Similar results were described after WJ-MSCs and HUCPVCs
secretome analysis [14,15,20]. Based on these results, the applica-
tion of MSCs secretome in CNS regeneration models, instead of cell
transplantation, seems to be a truly valid alternative.
In spite the growing amount of studies on MSCs and their
secretome in the last years, little is known about how cell passaging
might inﬂuence the secretome composition. In the regenerative
medicine ﬁeld this becomes even more relevant, since both cell
transplantation and secretome application require large numbers
of cells, which implies cellular expansion up to the required amount
through successive passaging.
A study focusing on how cell passaging impacts on MSCs
secretome is long overdue and so the aim of the present work was
to evaluate how cell passage impacts the effect of human adipose
tissue mesenchymal stem cells (hASCs) secretome at various pro-
cesses (survival, differentiation and axonal growth) in neuronal
populations.
The results allowed us to determine that, regardless of the
passage, hASCs secretome seems to promote consistently the same
effect on the maintenance of post-natal rat hippocampal primary
cultures, neuronal differentiation in human neural progenitor cells
(hNPCs) and axonal growth from a dorsal root ganglion (DRG)
model. This idea is reinforced by the fact that the expression of
several proteins involved in those processes also suffers no change
with passage number.
2. Materials and methods
2.1. Human adipose-derived stem cell culture
Human ASCs were isolated from human lipoaspirates obtained
from three consenting donors under an institutional review board
approved protocol at LaCell LLC. hASCs from three different donors
were kindly provided by Professor Jeffrey Gimble (LaCell LLC, New
Orleans, Louisiana, USA). Upon thawing, they were plated at a
density of 4.0 103 cells/cm2, they were cultured in a-MEM me-
dium (Invitrogen, USA), supplemented with 10% fetal bovine serum
(FBS) (Biochrom AG, Germany) and 1% penicillin-streptomycin
(Invitrogen, USA). Cultures were maintained at 37 C and 5% CO2,
with medium changes every 2 or 3 days, until conﬂuent.
2.2. hASC secretome (conditioned media, CM, collection)
Cells were plated at a density of 4.0 103 cells/cm2 (for cell
culture tests), or 12.0 103 cells/cm2 (for proteomic analysis) and
left for 72 h in a-MEM medium, supplemented and incubated thePlease cite this article as: S.C. Serra et al., Inﬂuence of passage number o
survival, neurodifferentiation and axonal growth, Biochimie, https://doi.osame way as above. Afterwards, medium was removed and cells
were washed three times with PBS, no Ca2þ or Mg2þ, (Invitrogen,
USA) and one time with Neurobasal A medium (Invitrogen, USA),
supplemented solely with 1% Kanamycin (Invitrogen, USA) - or
Neurobasal medium (Invitrogen, USA), supplemented with 1%
penicillin-streptomycin, in the case of future use with DRGs. After
washing, the same supplemented Neurobasal A - again, or Neuro-
basal - was added to the cells and left for 24 h, at the same incu-
bation parameters. Following this conditioning period, medium (i.e.
the secretome of hASCs) was collected and stored at 80 C, after a
ﬂash-freeze in liquid nitrogen, for usewhen needed. This procedure
was performed for collecting secretomes in P3, P6, P9 and P12.
2.3. Post-natal rat hippocampal primary culture and incubation
with hASCs-CM
Upon dissection of P4 Wistar Han brains, hippocampi were
submitted to a trypsin-based (Sigma, USA) enzymatic digestion,
followed by mechanical dissociation. The cells obtained this way
were plated, at a density of 4.0 104 cells/cm2, on coverslips coated
with poly-D-lysine (Sigma, USA). Cells were then incubated with
the previously collected secretomes for 7 days. At culture day 4, half
the volume was replaced.
2.4. Human neural progenitor cell culture and incubation with
hASCs-CM
hNPCs were kindly provided by Professor Leo A. Behie (Uni-
versity of Calgary, Calgary, Canada). Upon thawing, hNPCs in the
form of spheres were cultured in a serum-free medium, PPRFh2
[21]. After 2 days, spheres were harvested and mechanically
dissociated into a single cell suspension and cultured again with
fresh medium. Every 3 or 4 days, 40% of the used medium was
replaced. After 14e20 days, hNPCs were passaged and plated on a
pre-coated - poly-D-lysine and laminin (Sigma, USA) - 24-well
plate, at a density of 1.0 105 cells per well. The secretomes pre-
viously collected, at the day of the experiment further supple-
mentedwith 1% glutamax (Gibco, USA), were added immediately to
the cells and left for 5 days, at 37 C and 5% CO2. No medium
changes or additions were done during that period of time.
2.5. DRGs culture and incubation with hASCs-CM
To ensure DRGs adhesion, a matrix of collagen hydrogel droplets
was used. After preparation, collagen droplets were incubated for
2 h, at 37 C and 5% CO2. In themeanwhile, DRGswere isolated from
P5-P7 Wistar Han pups and at the end placed on top of the previ-
ously prepared collagen droplets. Secretomes from the different
passaged hASCs were then immediately added, after further sup-
plementation with B27, L-glutamine and glucose. DRGs were kept
in culture for 4 days, at 37 C and 5% CO2, with no medium being
replaced or added.
2.6. Immunocytochemistry
All cells/explants were ﬁxed using 4% paraformaldehyde,
permeated by incubatingwith 0.3% Triton X-100 in PBS and blocked
with 10% FBS in PBS. Following all these steps, incubation with
primary antibody was performed. Depending on the culture,
different antibodies were used as follows: a) mouse anti-
microtubule-associated protein 2 (MAP-2) (Sigma, USA) to detect
mature neurons in post-natal rat hippocampal primary cultures
and in hNPCs cultures; b) mouse anti-neuroﬁlament (NF) (Milli-
pore, USA) to identify neurite projections in DRGs cultures. After
washing with PBS, incubation with secondary antibody followed,n the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
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MAP-2 and Alexa Fluor 488 goat anti-mouse immunoglobulin G
(IgG) for NF. Cell samples obtained this way were observed under a
BX-61 ﬂuorescence microscope (Olympus, Germany). For this pur-
pose, three coverslips per condition and ten representative ﬁelds
were chosen and analyzed. In the case of post-natal rat hippo-
campal primary cultures, results are shown as percentage of MAP-2
positive cells over the total number of cells per ﬁeld of observation.
On the other hand, for hNPCs cultures results are represented by
the percentage of differentiated MAP-2 positive cells over the total
number of cells per ﬁeld of observation. For this purpose differ-
entiated cells were considered to be MAP-2 positive cells disclosing
the growth of neurites/axons from their cell bodies. Regarding
DRGs explants cultured on collagen hydrogel droplets, they were
imaged using a FV1000 confocal microscope (Olympus, Germany)
and analyzed with Image J software, in order to quantify the area
occupied by the neurites within the gel [22]. For that purpose,
image scale was ﬁrst set and then the area occupied by the DRG
itself was excluded. Images were then converted to 8 bits and bi-
nary. Through the “analyze particles” menu, the software auto-
matically calculated the area of neurite outgrowth, considering the
image dark background as contrast.
2.7. Untargeted Proteomics: mass spectrometry analysis
Replicates of secretomes from different donors for each passage
of hASCs were processed as previously described [23]. Secreted
proteins were precipitated from the concentrated medium using
the trichloroacetic acid-acetone procedure [24]. The protein pellets
were resuspended in 2 Laemmli buffer (BioRad), aided by ultra-
sonication and denaturation at 95 C. After denaturation, samples
were alkylated with acrylamide and subjected in gel digestion by
using the short-GeLC approach [25]. The formed peptides were
subjected to SPE using OMIX tips with C18 stationary phase (Agi-
lent Technologies, Glostrup, Denmark) before liquid
chromatography-tandemmass spectrometry (LC-MS/MS). Samples
were analyzed on a Triple TOF™ 5600 System (AB Sciex®) in two
phases: information-dependent acquisition (IDA) for protein
identiﬁcation and SWATH acquisition for protein quantiﬁcation
(detailed information in Supplementary Data). A speciﬁc library ofFig. 1. Percentage of MAP-2 positive cells (i.e. mature neurons) in post-natal rat hippocampa
P12. No statistically signiﬁcant differences found (one-way ANOVA, n¼ 3, mean± SD, p< 0
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ﬁles from the IDA experiments, and used for subsequent SWATH
processing. Libraries were obtained using Protein Pilot™ software
(v4.5, AB Sciex®) searching against the SwissProt database
(released October 2014).
SWATH data processing was performed using SWATH™ pro-
cessing plug-in for PeakView™ (v2.0.01, ABSciex®). Brieﬂy, peptides
were selected automatically from the library and up to 15 peptides
with up to 5 fragment ions were chosen per protein. Quantitation
was attempted for all proteins in the library ﬁle that were identiﬁed
below 5% local FDR from ProteinPilot™ searches, by extracting the
peak areas of the target fragment ions of the identiﬁed peptides
using an extracted-ion chromatogram (XIC) window of 4min with
20mDa XIC width.
All peptides that met the 1% FDR threshold were retained and
the levels of human proteins were estimated by summing all the
respective transitions and peptides that met the FDR criteria (an
adaptation of [26]). For comparisons between experiments, the
protein levels were normalized to the internal standard added after
medium collection.
2.8. Statistical analysis
All statistical analyses were performed using GraphPad Prism 6
forWindows (GraphPad Software). Differences among groups were
assessed by one-way ANOVA. A p-value <0.05 (95% conﬁdence
level) was set as the criteria for statistical signiﬁcance. All data are
presented as mean± standard deviation (SD).
3. Results
The purpose of our study was to determine the impact that cell
passaging might have on the secretome of hASCs, more speciﬁcally
in what way it affected its potential to promote maintenance of
post-natal rat hippocampal primary cultures as well as its ability to
induce neuronal differentiation in human neural progenitor cells or
axonal growth in a DRG model.
To determine the effects of the hASCs secretome, we started by
testing secretomes collected after different passages (P3, P6, P9 and
P12) in post-natal rat hippocampal primary cultures. After al neuronal primary cultures upon incubation with hASCs secretomes after P3, P6, P9 and
,05).
n the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
Fig. 2. Fluorescence microscopy representative pictures of post-natal hippocampal mature neuron cultures incubated with secretomes after P3 (A), P6 (B), P9 (C) and P12 (D),
marked for MAP-2 (red) and DAPI (blue, i.e. nucleus marker).
S.C. Serra et al. / Biochimie xxx (xxxx) xxx4standard culture period, immunocytochemistry for MAP-2 (mature
neuronal marker) positive cells was performed. Results revealed
that the incubation with the different CM collected did not show
statistically signiﬁcant differences in the percentage of mature
neurons (MAP-2þ cells) (Figs. 1 and 2).Fig. 3. Percentage of MAP-2 positive cells differentiated in hNPCs cultures after incubation
found (one-way ANOVA, n¼ 3, mean± SD, p < 0,05).
Please cite this article as: S.C. Serra et al., Inﬂuence of passage number o
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incubating hNPCs with the collected secretomes. After immuno-
cytochemistry for the same marker, the number of differentiated
MAP-2 positive cells was determined. No statistically signiﬁcant
differences were found in the percentage of differentiated cellswith hASCs secretomes after P3, P6, P9 and P12. No statistically signiﬁcant differences
n the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
Fig. 4. Fluorescence microscopy representative pictures of differentiation in hNPCs cultures incubated with secretomes after P3 (A), P6 (B), P9 (C) and P12 (D), marked for MAP-2
(red) and DAPI (blue).
S.C. Serra et al. / Biochimie xxx (xxxx) xxx 5among the cultures incubatedwith the different secretomes (Figs. 3
and 4).
In addition, the impact of hASCs secretomes on axonal growth,
through the incubation of DRGs in different secretomes, was also
evaluated. After incubation, immunocytochemistry for neuroﬁla-
ment was performed and the total area of neurite outgrowth wasFig. 5. Total area of neurite outgrowth for DRGs determined after incubation with hASCs sec
ANOVA, n¼ 3, mean ± SD, p< 0,05).
Please cite this article as: S.C. Serra et al., Inﬂuence of passage number o
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cant differences were detected, when comparing all secretomes
tested (Figs. 5 and 6).
In order to further understand the results obtained, a proteomic
analysis of the hASCs secretomes for the above referred passages
was performed, allowing the characterization of its protein proﬁleretomes after P3, P6, P9 and P12. No statistically signiﬁcant differences found (one-way
n the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
Fig. 6. Fluorescence microscopy representative pictures of neurite outgrowth in DRGs cultures incubated with secretomes after P3 (A),P6 (B), P9 (C) and P12 (D), marked for NF
(green, i.e. marker for neuroﬁlament).
S.C. Serra et al. / Biochimie xxx (xxxx) xxx6throughout successive passaging (Fig. 7).
From the heatmap obtained it is clear that all different passages
present a distinct proﬁle. However, when speciﬁcally analyzing
proteins associated to neuroprotection, neurodifferentiation and/or
axonal growth (Table 1) this was not the case. Indeed, for all
referred proteins, no differences were found among the CM
collected at P3, P6, P9 and P12 (Fig. 8).
An analysis, using STRING (Search Tool for the Retrieval of
Interacting Genes/Proteins; https://string-db.org/) database, was
also performed to identify the processes and pathways inwhich the
proteins presented in Table 1 could be involved (Fig. 1 e Supple-
mentary data).
4. Discussion
The availability of adipose tissue as well as a straightforward
isolation process, which leads to a high number of cells when
compared with other sources of MSC-like cells, makes the use of
hASCs attractive for CNS regenerative medicine purposes [27]. As
previously discussed, their therapeutic potential has been attrib-
uted to the neuroregulatory properties of the soluble factors they
secrete [13,14,19,28]. Indeed, previous works have reported that the
secretome of ASCs increases the viability of hippocampal cultures,
as well as the number of neurons in culture [14]. Moreover, it was
also shown that ASCs secretome has the ability to induce neuronal
differentiation of human neural progenitor cells [59]. Recently, it
has been shown that exposure to ASCs secretome promotes axonalPlease cite this article as: S.C. Serra et al., Inﬂuence of passage number o
survival, neurodifferentiation and axonal growth, Biochimie, https://doi.ogrowth [29,59]. In the present study we have observed that these
effects are not dependent on cell passaging. Indeed,none of the
parameters referred above and here in studied, was impacted by
the number of passages (P3-P12) of ASCs.
As the literature has reported, the ability of the hASCs secreted
factors in promoting neuronal survival and inducing differentiation
is well described. In fact, the presence of growth factors like VEGF,
HGF, IGF-1, TGF-b1 in the secretome of hASCs has been demon-
strated before [13,19]. The proteomic analysis performed in our
study identiﬁed several proteins, some of which have a neuro-
protective and/or neurodifferentiation role associated as well as
axonal growth promotion ability. The quantiﬁcation of the latter
did not reveal differences among the passages that were studied, a
fact that nicely correlates with the data obtained with the cell
culture experiments. Neverthles, they are a strong evidence of the
key role of ASCs secretome on regulating neuronal cell viability,
differentiation and axonal outgrowth.
For instance, heatshock protein 70 (Hsp70) is expressed in a
ubiquitous way and it possesses a neuroprotective effect in
neuronal cells [30]. In a similar way, it has also been described a
possible ubiquitin carboxy-terminal hydrolase L1 (UCHL1) protein
dysfunction in the pathogenesis of Parkinson and Alzheimer dis-
eases [31]. Chiba et al. demonstrated that the neurogenic effect
promoted by estrogen in the hippocampus of rats was due to their
ability to induce the expression of granulin [32]. The extended
presence of glia-derived nexin in the hippocampus after transient
ischemia delayed neuronal death and therefore a neuroprotectiven the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
Fig. 7. Heatmap for hASCs secretomes proteomic analysis, after passages P3, P6, P9 and P12 (n¼ 3/passage).
Table 1
List of proteins by neuronal function.
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Besides the above referred proteins, some others were detected
that are involved both in neuroprotection and neurodifferentiation.
For example, glycoprotein thrombospondin-1 has the ability to
promote the activation of TGF-b1, a cytokine known to have a
potent neurotrophic activity [34]. TGF-b1 was shown to be related
with the suppression of inﬂammatory processes and the promotion
of neuronal survival, as well as with the promotion of sprouting and
neurite outgrowth in rat hippocampal neuron cultures [35,36]. Its
role in the maintenance of hNPCs and promotion of their neuronal
differentiation was also already demonstrated [37].
The neuroprotective and neurodifferentiation character of other
proteins found such as pigment epithelium-derived factor (PEDF),
clusterin and galectin 1 has also been described in the literaturePlease cite this article as: S.C. Serra et al., Inﬂuence of passage number o
survival, neurodifferentiation and axonal growth, Biochimie, https://doi.o[38e42]. From these, galectin 1 stands out, as it is able to induce
BDNF production by astrocytes, a growth factor known to promote
neuronal survival [43].
Additionally, interleukin-6 (IL-6), a cytokine with a broad range
of functions, is also present within ASCs secretome. The inhibition
of apoptosis by NMDA channels was identiﬁed as the mechanism
responsible for its neuroprotective effect [44]. In the sameway, IL-6
derived from astrocytes has shown to promote neuronal differen-
tiation of neuronal progenitor cells [45]. On the other hand, the
exact mechanism through which DJ-1 works is still unknown, but it
was already demonstrated its protective role regarding neuronal
death [46]. Li et al. have reported a strong association between DJ-1
and neuronal stem cells differentiation [47].
Of the proteins mentioned, clusterin and galectin 1 also present
an ability to promote axonal growth. The literature shows more
than one example where clusterin has demonstrated the ability to
enhance neurite outgrowth and extension [48e50]. Concerning
galectin 1, it has been implicated in several processes related with
axon guidance and regeneration. As reviewed by Gaudet et al. [51],
it seems to be essential for the correct guidance of primary axons to
speciﬁc targets and also to be involved in the regenerative response
of axons after peripheral nerve injury. Quinta et al. [52] also related
its presence to the promotion of axonal regeneration in a model of
spinal cord injury.
Proteins related only with the promotion of axonal growth were
also detected. One example is Semaphorin 7A, that has previously
shown to enhance axon growth in central and peripheral nervous
system and is essential for axon formation in development [53]. Onn the impact of the secretome of adipose tissue stem cells on neural
rg/10.1016/j.biochi.2018.09.012
Fig. 8. Identiﬁcation of proteins with neuroregulatory character within the P3, P6, P9
and P12 secretomes of ASCs. (one-way ANOVA, n¼ 3, mean ± SD, p< 0,05).
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sion [54] and to be involved in the regulation of axon elongation
[55], both in a model of spinal cord explants. Lee et al. [56] showed
that blocking nidogen function in a model of peripheral nerve
injury stopped regeneration of axons in adult sensory neurons,
suggesting an essential role of this molecule in such process.
Another example is glypican-1, which has more than once been
implicated in the promotion of neurite outgrowth [57,58].
The STRING analysis showed that all the proteins already
mentioned are involved in different pathways concerning neuro-
protection, neurodifferentiation and/or axonal growth. Of these,
the most relevant are some signaling pathways, namely PI3K-AKT
[60e62], Wnt [63e65], mTOR [66e68], VEGF [69e71] and Notch
[72,73], and also other processes such as Hsp70 protein binding
[74,75], axonogenesis and axon guidance.5. Conclusions
Our results demonstrate that successive cellular passaging does
not signiﬁcantly inﬂuence the neuroregulatory proteic proﬁle of
hASCs secretome and its ability to induce neurodifferentiation,
post-natal neuronal survival and axonal growth. Together with the
fact that adipose tissue stem cells maintain their phenotype and the
properties that deﬁne them as MSCs throughout successive
passaging the results obtained may allow for a longer applicability
window, by possibly facilitating the cellular expansion process
necessary to obtain the large numbers of cells usually needed.
To determine whether or not cellular passaging inﬂuences
secretome properties is a sole characteristic of ASCs or common to
all MSCs, future studies with a similar experimental design should
be performed using MSCs from different sources, such as bone
marrow and umbilical cord tissue.Acknowledgements
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